Latest News about SNY
Recent news which mentions SNY
Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts
October 06, 2023
From Benzinga
What's Going On With Mirati Therapeutics Stock?
October 06, 2023
From Benzinga
From Benzinga
Teva partnership with Sanofi ‘will pay dividends,’ analyst says
October 04, 2023
From MarketWatch
Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
October 04, 2023
From Benzinga
From Benzinga
Why Shares of Kymera Therapeutics Jumped on Tuesday
October 03, 2023
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Split Watch: Is Regeneron Pharmaceuticals Next?
September 30, 2023
From Motley Fool
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
September 28, 2023
From Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
From Benzinga
Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate
September 27, 2023
From Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
From Benzinga
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
September 25, 2023
From Benzinga
Pfizer maternal RSV vaccine recommended by CDC advisers
September 22, 2023
From MarketWatch
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
September 21, 2023
From Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 21, 2023
From Benzinga
Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
September 21, 2023
From Benzinga
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
September 21, 2023
From Benzinga
From Benzinga
From Benzinga
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray
September 20, 2023
From Benzinga
3 Stocks to Buy to Ride Europe’s Coming Market Surge
September 19, 2023
From InvestorPlace
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
September 14, 2023
From Benzinga
This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now
September 14, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.